Share Email Print
cover

Proceedings Paper

Developing clinical trials for breast cancer interstitial therapy
Author(s): David S. Robinson; Jean-Marie A. Parel; Peter J. Milne; Fabrice Manns; David B. Denham
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

To bring the current laboratory and feasibility studies to successful, focused clinical trials, several important considerations must be met. These include tumor selection, patient selection, treatment method, assessment of the treatment field, and short and long term clinical strategies.

Paper Details

Date Published: 22 June 1999
PDF: 3 pages
Proc. SPIE 3590, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems IX, (22 June 1999); doi: 10.1117/12.351006
Show Author Affiliations
David S. Robinson, St. Luke's Hospital Breast Ctr. (United States)
Jean-Marie A. Parel, Bascom Palmer Eye Institute/Univ. of Miami (United States)
Peter J. Milne, Univ. of Miami (United States)
Fabrice Manns, Bascom Palmer Eye Institute/Univ. of Miami and Univ. of Miami (United States)
David B. Denham, Univ. of Miami School of Medicine (United States)


Published in SPIE Proceedings Vol. 3590:
Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems IX
Kenton W. Gregory; R. Rox Anderson; David S. Robinson; Reza S. Malek; Lou Reinisch; Darryl J. Bornhop; Kenneth Eugene Bartels; Hans-Dieter Reidenbach; Lloyd P. Tate; C. Gaelyn Garrett; Eugene A. Trowers; Aaron P. Perlmutter; Kenneth Eugene Bartels; Lawrence S. Bass; Darryl J. Bornhop; C. Gaelyn Garrett; Kenton W. Gregory; Nikiforos Kollias; Harvey Lui; Reza S. Malek; Aaron P. Perlmutter; Hans-Dieter Reidenbach; Lou Reinisch; David S. Robinson; Lloyd P. Tate; Eugene A. Trowers, Editor(s)

© SPIE. Terms of Use
Back to Top